accountNEW YORK (MarketWatch) -- Cardinal Health Inc. /quotes/comstock/13*!cah/quotes/nls/cah (CAH 35.88, -0.28, -0.77%) said Monday it purchased privately-held Zuellig Pharma China for $470 million, extending its distribution presence in one of the world...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Cardinal Health buys Chinese drug distributor
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account